Expression of B7‐H3 and TIM‐3 in gastric‐type endocervical adenocarcinoma: prevalence, association with PD‐L1 expression, and prognostic significance
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Expression of B7‐H3 and TIM‐3 in gastric‐type endocervical adenocarcinoma: prevalence, association with PD‐L1 expression, and prognostic significance
Authors
Keywords
-
Journal
Journal of Pathology Clinical Research
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2023-10-07
DOI
10.1002/cjp2.345
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Assessment of HER2 in Gastric-Type Endocervical Adenocarcinoma and its Prognostic Significance
- (2023) Su Wang et al. MODERN PATHOLOGY
- Discordance of PD-L1 expression in primary and metastatic ovarian high-grade serous carcinoma and its correlation with CD8 + tumor-infiltrating lymphocytes and patient prognosis
- (2023) Tao Zhang et al. VIRCHOWS ARCHIV
- Prevalence and prognostic significance of PD-L1, TIM-3 and B7-H3 expression in endometrial serous carcinoma
- (2022) Hao Chen et al. MODERN PATHOLOGY
- Oncolytic virus expressing PD-1 inhibitors activates a collaborative intratumoral immune response to control tumor and synergizes with CTLA-4 or TIM-3 blockade
- (2022) Fei Ju et al. Journal for ImmunoTherapy of Cancer
- Gastric-type adenocarcinoma of the cervix: Clinical outcomes and genomic drivers
- (2022) Sarah Ehmann et al. GYNECOLOGIC ONCOLOGY
- Gastric-Type Adenocarcinoma of the Uterine Cervix Associated with Poor Response to Definitive Radiotherapy
- (2022) Airi Kuruma et al. Cancers
- TIM-3 as a Prognostic Marker and a Potential Immunotherapy Target in Human Malignant Tumors: A Meta-Analysis and Bioinformatics Validation
- (2021) Kui Zang et al. Frontiers in Oncology
- Phase I/Ib clinical trial of Sabatolimab, an Anti-TIM-3 Antibody, Alone and in Combination With Spartalizumab, an Anti-PD-1 Antibody, in Advanced Solid Tumors
- (2021) Giuseppe Curigliano et al. CLINICAL CANCER RESEARCH
- Targeting STAT3 Abrogates Tim-3 Upregulation of Adaptive Resistance to PD-1 Blockade on Regulatory T Cells of Melanoma
- (2021) Lili Huang et al. Frontiers in Immunology
- The Role of CD276 in Cancers
- (2021) Shengzhuo Liu et al. Frontiers in Oncology
- PD-L1 expression in tumor cells is associated with a favorable prognosis in patients with high-risk endometrial cancer
- (2021) Liju Zong et al. GYNECOLOGIC ONCOLOGY
- PD‐L1 expression in HPV‐independent cervical adenocarcinoma and its prognostic significance
- (2021) Lili Chen et al. HISTOPATHOLOGY
- Expression of B7-H3 Correlates with PD-L1 and Poor Prognosis in Patients with Cervical Cancer
- (2021) Qianqian Zhang et al. OncoTargets and Therapy
- B7-H3/CD276: An Emerging Cancer Immunotherapy
- (2021) Wu-Tong Zhou et al. Frontiers in Immunology
- Targeting Tim-3 in Cancer With Resistance to PD-1/PD-L1 Blockade
- (2021) Tian Tian et al. Frontiers in Oncology
- Targeting the immune checkpoint B7-H3 for next-generation cancer immunotherapy
- (2021) Chuan Liu et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Expression of B7 family checkpoint proteins in cervical cancer
- (2021) Liju Zong et al. MODERN PATHOLOGY
- Looking past PD-L1: expression of immune checkpoint TIM-3 and its ligand galectin-9 in cervical and vulvar squamous neoplasia
- (2020) Jacob Curley et al. MODERN PATHOLOGY
- PD-L1 Expression and CD8+ Tumor-infiltrating Lymphocytes in Different Types of Tubo-Ovarian Carcinoma and Their Prognostic Value in High-grade Serous Carcinoma
- (2020) Hao Chen et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Immune checkpoint signaling and cancer immunotherapy
- (2020) Xing He et al. CELL RESEARCH
- Expression and Significance of Immune Checkpoints in Clear Cell Carcinoma of the Uterine Cervix
- (2020) Liju Zong et al. Journal of Immunology Research
- Dual but not single PD-1 or TIM-3 blockade enhances oncolytic virotherapy in refractory lung cancer
- (2020) Fan Sun et al. Journal for ImmunoTherapy of Cancer
- Prognostic Values of TIM-3 Expression in Patients With Solid Tumors: A Meta-Analysis and Database Evaluation
- (2020) Shuang Qin et al. Frontiers in Oncology
- PD-L1 Expression in Endocervical Adenocarcinoma
- (2020) Glorimar Rivera-Colon et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Tumor mutational load predicts survival after immunotherapy across multiple cancer types
- (2019) Robert M. Samstein et al. NATURE GENETICS
- Analysis of gastric-type mucinous carcinoma of the uterine cervix — An aggressive tumor with a poor prognosis: A multi-institutional study
- (2019) Shin Nishio et al. GYNECOLOGIC ONCOLOGY
- Efficacy and Safety of Pembrolizumab in Previously Treated Advanced Cervical Cancer: Results From the Phase II KEYNOTE-158 Study
- (2019) Hyun Cheol Chung et al. JOURNAL OF CLINICAL ONCOLOGY
- The impact of programmed cell death-ligand 1 (PD-L1) and CD8 expression in grade 3 endometrial carcinomas
- (2019) Stylianos Vagios et al. International Journal of Clinical Oncology
- The role of PD-L1 expression as a predictive biomarker: an analysis of all US Food and Drug Administration (FDA) approvals of immune checkpoint inhibitors
- (2019) Andrew A. Davis et al. Journal for ImmunoTherapy of Cancer
- International Endocervical Adenocarcinoma Criteria and Classification (IECC)
- (2018) Simona Stolnicu et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Cancer immunotherapy using checkpoint blockade
- (2018) Antoni Ribas et al. SCIENCE
- Roles of B7-H3 in Cervical Cancer and Its Prognostic Value
- (2018) Sai Han et al. Journal of Cancer
- Cancer of the cervix uteri
- (2018) Neerja Bhatla et al. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
- Second- and third-generation drugs for immuno-oncology treatment—The more the better?
- (2017) Wolfram C.M. Dempke et al. EUROPEAN JOURNAL OF CANCER
- Tim-3 and its role in regulating anti-tumor immunity
- (2017) Madhumita Das et al. IMMUNOLOGICAL REVIEWS
- Chemoresistance of Gastric-Type Mucinous Carcinoma of the Uterine Cervix
- (2017) Atsumi Kojima et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Safety and Efficacy of Pembrolizumab in Advanced, Programmed Death Ligand 1–Positive Cervical Cancer: Results From the Phase Ib KEYNOTE-028 Trial
- (2017) Jean-Sebastien Frenel et al. JOURNAL OF CLINICAL ONCOLOGY
- B7-H3 promotes the proliferation, migration and invasiveness of cervical cancer cells and is an indicator of poor prognosis
- (2017) Yi Li et al. ONCOLOGY REPORTS
- Resistance to checkpoint blockade therapy through inactivation of antigen presentation
- (2017) Moshe Sade-Feldman et al. Nature Communications
- Loss of IFN-γ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy
- (2016) Jianjun Gao et al. CELL
- B7-H3, B7-H4, Foxp3 and IL-2 expression in cervical cancer: Associations with patient outcome and clinical significance
- (2016) CHENGLIN HUANG et al. ONCOLOGY REPORTS
- Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints
- (2016) Shohei Koyama et al. Nature Communications
- Gastric-type Endocervical Adenocarcinoma
- (2015) Yevgeniy S. Karamurzin et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Classifying Cancers Based on T-cell Infiltration and PD-L1
- (2015) Michele W.L. Teng et al. CANCER RESEARCH
- Enhanced expression of PD L1 in cervical intraepithelial neoplasia and cervical cancers
- (2015) Louisa Mezache et al. MODERN PATHOLOGY
- Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
- (2014) Roy S. Herbst et al. NATURE
- PD-1 blockade induces responses by inhibiting adaptive immune resistance
- (2014) Paul C. Tumeh et al. NATURE
- Tim-3 Expression in Cervical Cancer Promotes Tumor Metastasis
- (2013) Yang Cao et al. PLoS One
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Colocalization of Inflammatory Response with B7-H1 Expression in Human Melanocytic Lesions Supports an Adaptive Resistance Mechanism of Immune Escape
- (2012) J. M. Taube et al. Science Translational Medicine
- Adenoma malignum of the uterine cervix: ultrasonographic findings in 11 patients
- (2011) S. B. Park et al. ULTRASOUND IN OBSTETRICS & GYNECOLOGY
- Absence of High-Risk Human Papillomavirus (HPV) Detection in Endocervical Adenocarcinoma with Gastric Morphology and Phenotype
- (2010) Yasuki Kusanagi et al. AMERICAN JOURNAL OF PATHOLOGY
- B7-H3 and Its Role in Antitumor Immunity
- (2010) Martin Loos et al. Clinical & Developmental Immunology
- TIM-3 is expressed on activated human CD4+ T cells and regulates Th1 and Th17 cytokines
- (2009) William D. Hastings et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- PD-1 and Its Ligands in Tolerance and Immunity
- (2008) Mary E. Keir et al. Annual Review of Immunology
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started